Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05FUY
|
|||
Former ID |
DNC005581
|
|||
Drug Name |
1,8-Dichloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol
|
|||
Synonyms |
CHEMBL192876; 1,8-Dichloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol; SCHEMBL4456831; YTFVBUBYMJJWQZ-UHFFFAOYSA-N; ZINC13645103; BDBM50168322
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H10Cl2O2
|
|||
Canonical SMILES |
C1=CC(=CC=C1C2=CC(=C3C(=C2)C=CC(=C3Cl)O)Cl)O
|
|||
InChI |
1S/C16H10Cl2O2/c17-13-8-11(9-1-4-12(19)5-2-9)7-10-3-6-14(20)16(18)15(10)13/h1-8,19-20H
|
|||
InChIKey |
YTFVBUBYMJJWQZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity. J Med Chem. 2005 Jun 16;48(12):3953-79. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.